Treatment of premenopausal patients with advanced or recurrent breast cancer by chemical ablation / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 60-62, 2003.
Artículo
en Chino
| WPRIM
| ID: wpr-301898
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the clinical efficacy and safety of luteinizing hormone releasing hormone (LH-RH) analog in premenopausal patients with advanced or recurrent breast cancer.</p><p><b>METHODS</b>LH-RH analog (enantone 3.75 mg/2 ml) were administered to 28 premenopausal patients with advanced recurrent breast cancer and its efficacy and side effect were observed.</p><p><b>RESULTS</b>The response rate (complete response and partial response) was 42.9%, and after 8 weeks of treatment, the plasma estrogen in all patients decreased to the level of postmenopause. No major adverse events were observed.</p><p><b>CONCLUSIONS</b>LH-RH analog is effective and safe for premenopausal breast cancer with low adverse reaction and its administration method is easy.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Sangre
/
Neoplasias de la Mama
/
Hormona Luteinizante
/
Hormona Liberadora de Gonadotropina
/
Leuprolida
/
Premenopausia
/
Usos Terapéuticos
/
Quimioterapia
/
Estrógenos
/
Recurrencia Local de Neoplasia
Límite:
Adulto
/
Femenino
/
Humanos
Idioma:
Chino
Revista:
Acta Academiae Medicinae Sinicae
Año:
2003
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS